Breaking News
Get 40% Off 0
☕ Buy the dip? After losing 17%, Starbucks sees an estimated 20% upside. See the top Undervalued stocks! Unlock list
Close

Morphic Holding Inc (MORF)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Morphic Holding's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
29.90 +1.19    +4.14%
04/05 - Closed. Currency in USD ( Disclaimer )
After Hours
29.71
-0.19
-0.64%
5:30:08 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 312,236
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 29.17 - 30.26
Morphic Holding 29.90 +1.19 +4.14%

Morphic Holding Inc Company Profile

 
Get an in-depth profile of Morphic Holding Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

115

Equity Type

ORD

Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, and metabolic diseases, as well as fibrosis and cancer. Its lead product candidate MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation is in Phase 2 clinical trials for the treatment of inflammatory bowel disease. The company’s products in pipeline include Next Gen a4ß7 Inhibitors for additional potential GI indications, such as EGIDs, pouchitis, etc.; avß8 for the treatment of Myelofibrosis and solid tumor; and fibronectin integrin for pulmonary hypertensive. In addition, it has a license agreement with Janssen to discover and develop novel integrin therapeutics; collaboration agreement with Schrödinger for integrin targets; and license agreement with Children’s Medical Center Corporation to develop and commercialize products worldwide for any therapeutic or diagnostic use in humans and veterinary applications. Morphic Holding, Inc. was incorporated in 2014 and is headquartered in Waltham, Massachusetts.

Contact Information

Address 35 Gatehouse Drive, A2
Waltham, 02451
United States
Phone 781 996 0955
Fax -

Top Executives

Name Age Since Title
Gustav A. Christensen 73 2016 Independent Chairman
Yury V. Popov - - Member of Scientific Advisory Board
Scott L. Friedman - - Member of Scientific Advisory Board
Susannah Gray 61 2021 Independent Director
Norbert W. Bischofberger 66 2019 Independent Director
Martin William Edwards 66 2020 Independent Director
Amir H. Nashat 50 2017 Independent Director
Albert J. Robichaud 62 - Member of Scientific Advisory Board
Ulrich H. von Andrian-Werburg - - Member of Scientific Advisory Board
Shelia M. Violette - - Member of Scientific Advisory Board
Joseph P. Slattery 58 2019 Independent Director
Brian G. Feagan - - Member of Clinical Advisory Board
Nisha Nanda 48 2021 Independent Director
Silvio Danese - - Member of Clinical Advisory Board
Laurent Peyrin-Biroulet - - Member of Clinical Advisory Board
Bruce E. Sands - - Member of Clinical Advisory Board
Stefan Schreiber 61 2023 Member of Clinical Advisory Board
Praveen P. Tipirneni 56 2015 CEO, MD & Director
Timothy A. Springer 76 2014 Founder, Independent Director & Member of Scientific Advisory Board
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

MORF Comments

Write your thoughts about Morphic Holding Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email